VALIC Company I Science & Technology Fund (VCSTX)

Overview

The described fund is specialized in investing primarily in the equity of companies that are directly benefiting from advancements in technology and sciences. It allocates at least 80% of its net assets towards the common stocks of these companies. The fund shows a global perspective by allowing up to 50% of its total assets to be invested in foreign securities, highlighting its aim to capture growth across global markets. Notably, it also considers emerging markets by allocating up to 30% of its total assets to companies either organized or headquartered in these regions, though it limits exposure to any single emerging market country to 20% of its total assets. This strategic allocation reflects the fund's approach to diversify risk while seeking growth in dynamic sectors and regions worldwide. Despite its broad investment remit, the fund classifies itself as non-diversified, suggesting a focus on potentially higher risk and higher reward investments within the science and technology sectors.

Products and Services

• Equity Investments in Science and Technology Companies

  Investment in common stocks of companies expected to benefit from the development, advancement, and use of science and technology. This core offering targets the dynamic sectors where innovation could drive substantial growth, aiming to provide investors with significant returns by capitalizing on the advancements in these industries.

• International and Emerging Market Investments

  Up to 50% of the fund's total assets can be invested in foreign securities, including those in emerging markets, with a specific cap of 30% for emerging market companies and no more than 20% in any one emerging market country. This diversification strategy aims to tap into the growth potential of global markets and emerging economies, offering investors exposure to the rapid development occurring outside of the more established markets.